Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group

被引：3

作者：

de Cap, Maximiliano Ramia ^{[1
,2
,3
]}

Wu, Leo ^{[1
,2
]}

Hirt, Christian ^{[1
,2
]}

Pihan, German A. ^{[1
,2
]}

Patel, Sanjay S. ^{[4
]}

Tam, Wayne ^{[4
]}

Bueso-Ramos, Carlosn E. ^{[5
]}

Kanagal-Shamanna, Rashmi ^{[5
]}

Raess, Philipp W. ^{[6
]}

Siddon, Alexa ^{[7
]}

Narayanan, Damodaran ^{[1
,8
]}

Morgan, Elizabeth A. ^{[1
,8
]}

Pinkus, Geraldine S. ^{[1
,8
]}

Mason, Emily F. ^{[9
]}

Hsi, Eric D. ^{[10
]}

Rogers, Heesun J. ^{[11
]}

Toth, Laura ^{[12
]}

Foucar, Kathryn ^{[12
]}

Hurwitz, Stephanie N. ^{[13
]}

Bagg, Adam ^{[13
]}

Rets, Anton ^{[14
,15
]}

George, Tracy I. ^{[14
,15
]}

Orazi, Attilio ^{[16
]}

Arber, Daniel A. ^{[17
]}

Hasserjian, Robert P. ^{[1
,18
]}

Weinberg, Olga K. ^{[19
]}

机构：

[1] Harvard Med Sch, Boston, MA USA

[2] Beth Israel Deaconess Med Ctr, Boston, MA USA

[3] North Bristol NHS Trust, Bristol, England

[4] Weill Cornell Med Coll, New York, NY USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[6] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR USA

[7] Yale Sch Med, New Haven, CT USA

[8] Brigham & Womens Hosp, Boston, MA USA

[9] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[10] Wake Forest Baptist Hlth, Winston Salem, NC USA

[11] Cleveland Clin, Cleveland, OH USA

[12] Univ New Mexico, Dept Pathol, Albuquerque, NM USA

[13] Univ Penn, Dept Pathol, Philadelphia, PA USA

[14] ARUP Labs, Salt Lake City, UT USA

[15] Univ Utah, Dept Pathol, Salt Lake City, UT USA

[16] Texas Tech Univ Hlth Sci Ctr, Lubbock, TX USA

[17] Univ Chicago, Dept Pathol, Chicago, IL USA

[18] Massachusetts Gen Hosp, Boston, MA USA

[19] UT Southwestern Med Ctr, Dallas, TX USA

来源：

LEUKEMIA & LYMPHOMA | 2023年 / 64卷 / 05期

关键词：

Hematopoiesis; leukemic progenitor cells; neoplasia; genetic and other predisposing conditions; myeloid leukemias and dysplasias; HEALTH-ORGANIZATION CLASSIFICATION; GRANULOCYTIC-SARCOMA; LEUKEMIA; OUTCOMES;

D O I：

10.1080/10428194.2023.2185091

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Myeloid sarcoma (MS) is currently considered equivalent to de novo acute myeloid leukemia (AML); however, the relationship between these entities is poorly understood. This retrospective multi-institutional cohort study compared 43 MS with NPM1 mutation to 106 AML with NPM1 mutation. Compared to AML, MS had more frequent cytogenetic abnormalities including complex karyotype (p = .009 and p = .007, respectively) and was enriched in mutations of genes involved in histone modification, including ASXL1 (p = .007 and p = .008, respectively). AML harbored a higher average number of gene mutations (p = .002) including more frequent PTPN11 mutations (p < .001) and mutations of DNA-methylating genes including DNMT3A and IDH1 (both p < .001). MS had significantly shorter overall survival (OS) than AML (median OS: 44.9 vs. 93.2 months, respectively, p = .037). MS with NPM1 mutation has a unique genetic landscape, and poorer OS, compared to AML with NPM1 mutation.

引用

页码：972 / 980

页数：9

共 50 条

[1] NPM1 mutation in AML:: WHO and why?
Grimwade, David
BLOOD, 2006, 108 (13) : 3965 - 3965
[2] Clinical and Genomic Findings of Myeloid Sarcoma with an Emphasis on NPM1 Mutations: A study from the Bone Marrow Pathology Group
de Cap, Maximiliano Ramia
Wu, Leo
Pihan, German
Patel, Sanjay
Tam, Wayne
Bueso-Ramos, Carlos
Kanagal-Shamanna, Rashmi
Raess, Phil
Siddon, Alexa
Narayanan, Damodaran
Morgan, Elizabeth
Pinkus, Geraldine
Mason, Emily
Hsi, Eric
Rogers, Heesun
Toth, Laura
Foucar, Kathryn
Hurwitz, Stephanie
Bagg, Adam
Rets, Anton
George, Tracy
Orazi, Attilio
Arber, Daniel
Hasserjian, Robert
Weinberg, Olga
LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 884 - 885
[3] Therapy-related myeloid sarcoma with an NPM1 mutation
Bhatta, Sumita
Kut, Victoria
Petronic-Rosic, Vesna
Hyjek, Elizabeth
Larson, Richard A.
LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2130 - 2131
[4] Clinical and Genomic Findings of Myeloid Sarcoma with an Emphasis on NPM1 Mutations: A study from the Bone Marrow Pathology Group
de Cap, Maximiliano Ramia
Wu, Leo
Pihan, German
Patel, Sanjay
Tam, Wayne
Bueso-Ramos, Carlos
Kanagal-Shamanna, Rashmi
Raess, Phil
Siddon, Alexa
Narayanan, Damodaran
Morgan, Elizabeth
Pinkus, Geraldine
Mason, Emily
Hsi, Eric
Rogers, Heesun
Toth, Laura
Foucar, Kathryn
Hurwitz, Stephanie
Bagg, Adam
Rets, Anton
George, Tracy
Orazi, Attilio
Arber, Daniel
Hasserjian, Robert
Weinberg, Olga
MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 884 - 885
[5] The Clinicopathologic Significance of NPM1 Mutation and Ability to Detect NPM1 by Immunohistochemistry in Non-AML Myeloid Neoplasms
Kaseb, Hatem
Visconte, Valeria
Socha, Daniel
Crane, Genevieve
Durkin, Lisa
Cook, James
Maciejewski, Jarslow
Hsi, Eric
Rogers, Heesun
MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 860 - 861
[6] The Clinicopathologic Significance of NPM1 Mutation and Ability to Detect NPM1 by Immunohistochemistry in Non-AML Myeloid Neoplasms
Kaseb, Hatem
Visconte, Valeria
Socha, Daniel
Crane, Genevieve
Durkin, Lisa
Cook, James
Maciejewski, Jarslow
Hsi, Eric
Rogers, Heesun
LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 860 - 861
[7] Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML
Diaz de la Guardia, Rafael
Gonzalez-Silva, Laura
Lopez-Millan, Belen
Rodriguez-Sevilla, Juan Jose
Baroni, Matteo L.
Bueno, Clara
Anguita, Eduardo
Vives, Susana
Palomo, Laura
Lapillonne, Helene
Varela, Ignacio
Menendez, Pablo
GENES, 2020, 11 (01)
[8] The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms
Kaseb, Hatem
Visconte, Valeria
Socha, Daniel S. S.
Crane, Genevieve M. M.
Durkin, Lisa
Cook, James R. R.
Maciejewski, Jaroslaw P. P.
Hsi, Eric D. D.
Rogers, Heesun J. J.
GENES CHROMOSOMES & CANCER, 2023, 62 (10): : 573 - 580
[9] Establishment of an NPM1 Mutation Copy Number Estimator for Xpert ® NPM1 Mutation Test
Liu, Mengying
Liu, Mengying
Liu, Yuanyuan
Wei, Huilin
Tran, Tran
Yuan, Lin
Day, Gwo-Jen
BLOOD, 2023, 142
[10] AML masquerading as stroke: NPM1 mutation impact
Vicente Perez, L. D. C.
CLINICA CHIMICA ACTA, 2024, 558

← 1 2 3 4 5 →